The diagnosis hits hard—cancer, chronic respiratory disease, or another serious condition that doctors now link to your CPAP machine, the very device prescribed to help you breathe safely through the night. Beyond the fear and medical uncertainty, you’re facing treatment costs that insurance may dispute, lost wages from time away from work, and the overwhelming question of how a supposedly safe medical device could have poisoned you while you slept.
Tell us about your situation to see if you have a case.
At OnderLaw, we understand these immediate pressures because we’ve guided thousands of medical device victims through similar crises over our decades of practice, and we’re ready to help you pursue the compensation you may be entitled to through a free consultation with no upfront costs—call us today at (314) 408-6136. Our team has recovered over $5 billion in negotiated settlements for injured clients, and we bring that same commitment to every CPAP recall case we handle.
Unlike many firms that treat clients like case numbers, we provide direct attorney access throughout your case, ensuring you work with experienced lawyers who understand both the legal complexities and personal challenges you’re facing after a serious collision.
“Every case is an opportunity to protect someone else’s family from tragedy”
The Philips CPAP recall represents one of the most significant medical device failures in history, involving toxic foam degradation that exposed millions of users to harmful chemicals while they slept. Understanding the scope, science, and corporate timeline behind this crisis is essential for evaluating your potential legal claim.
When you trusted a CPAP machine to treat your sleep apnea, you never imagined that the device helping you breathe at night could release toxic chemicals and degraded foam particles directly into your airways. In June 2021, Philips Respironics announced one of the largest medical device recalls in history, affecting approximately 15 million devices worldwide with over 5 million in the United States alone, according to FDA data (2021). The FDA classified this as a Class I recall—their most serious designation reserved for devices that may cause serious injury or death—because the polyethylene-polyurethane (PE-PUR) sound abatement foam inside these machines can break down into dangerous particles and release volatile organic compounds that users inhale throughout the night. This systematic failure affects dozens of device models manufactured over more than a decade, including popular DreamStation CPAP machines, BiPAP devices, and even life-supporting ventilators used in hospitals and homes across St. Louis and throughout Missouri.
The science behind this degradation reveals why the recall has generated such widespread concern among medical professionals and regulatory authorities. The PE-PUR foam, originally designed to reduce machine noise, deteriorates through normal use and environmental factors like heat and humidity, creating both visible black particles and invisible chemical off-gassing that includes known carcinogens. While Philips initially suggested that certain cleaning methods like ozone cleaners accelerated the breakdown, subsequent testing revealed that degradation occurs even with proper maintenance and standard use conditions, meaning that millions of users faced exposure regardless of how carefully they followed instructions.
The polyurethane foam crisis represents more than a simple manufacturing defect—it’s a fundamental design failure that exposes users to documented carcinogens and toxic compounds every time they use their prescribed therapy. Laboratory testing has identified multiple harmful chemicals released during PE-PUR foam degradation, including toluene diamine (TDA), a compound classified as a potential human carcinogen by international health agencies, along with other volatile organic compounds that can cause respiratory irritation, inflammation, and systemic toxicity. Because CPAP users typically wear their masks for six to eight hours nightly, the cumulative exposure to these toxins over months or years creates significant health risks that medical experts are only beginning to fully understand, particularly for those who used the devices for a decade or more before the recall announcement.
Our greatest results have been the relationships we’ve forged with clients we’ve helped and the lives they’ve achieved after horrific accidents with the settlements our work brought about.
Every case is different and handled differently, but we are proud of what we have accomplished on behalf of previous clients. From multi-billion dollar mass tort settlements to individual personal injury verdicts, we fight for every penny of compensation our clients deserve.
Past results do not guarantee future outcomes, every case is different*
This section covers the health conditions linked to CPAP foam exposure and which injuries may qualify for compensation. You’ll understand how the exposure pathway creates specific injury patterns and what medical documentation strengthens your claim.
The health consequences of inhaling degraded foam particles and toxic chemicals manifest in ways that directly correlate with the exposure pathway, creating a distinct pattern of injuries among CPAP users that medical experts can identify. Respiratory system cancers—including lung cancer, throat cancer, and nasal cavity tumors—represent the most serious outcomes, as these organs receive direct, concentrated exposure to carcinogens during every therapy session, particularly in users who maintained consistent nightly use over years or decades.
Beyond cancer, users report developing severe respiratory conditions such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and treatment-resistant asthma that significantly impair their quality of life and ability to work, often requiring ongoing medical treatment and lifestyle modifications that create substantial economic and personal burdens.
The systemic effects extend beyond the respiratory tract because inhaled toxins enter the bloodstream through lung tissue, potentially affecting organs throughout the body in ways that researchers continue to investigate. Medical researchers have documented cases of kidney cancer, liver damage, and blood disorders among long-term CPAP users, though establishing causation for these conditions requires careful medical evaluation and expert testimony that connects the exposure to the specific injury.
Among the various injuries linked to CPAP foam degradation, certain cancer types present particularly strong legal claims due to their direct connection to the inhalation exposure pathway and supporting scientific evidence that establishes biological plausibility. Lung cancer claims, especially in non-smokers or former smokers who quit years before CPAP use, demonstrate the clearest causal relationship because the carcinogenic particles and chemicals travel directly into lung tissue with every breath taken through the device, creating a concentrated exposure that distinguishes these cases from environmental or occupational exposures. Head and neck cancers—including throat, sinus, and nasal cavity tumors—similarly benefit from proximity to the exposure source.
Additionally, many users experience immediate symptoms like persistent coughing, chest pain, headaches, and sinus infections that, while less severe than cancer, still require medical treatment and impact daily functioning in ways that may qualify for compensation.
This section explains how the federal litigation works and what it means for your case. You’ll learn about the MDL process, how it differs from a class action, and what progress has been made toward resolving claims.
The Judicial Panel on Multidistrict Litigation recognized the national scope of the CPAP crisis by consolidating thousands of federal lawsuits into MDL-3014 in the Western District of Pennsylvania, creating a coordinated legal process that benefits individual plaintiffs while ensuring consistent handling of common issues that affect all cases. This consolidation, established by the JPML in 2021, allows for centralized discovery, coordinated expert testimony, and efficient resolution of pretrial matters that would otherwise require duplication across hundreds of different courts, saving time and resources while ensuring that critical evidence and legal arguments receive thorough development. Judge Joy Flowers Conti oversees the MDL proceedings, managing everything from discovery disputes to settlement negotiations while ensuring that individual plaintiffs retain their right to pursue full compensation for their unique injuries, which distinguishes this process from other forms of consolidated litigation.
The MDL structure differs significantly from a class action lawsuit, a distinction that matters greatly for understanding your rights and options as a CPAP victim who may be entitled to individualized compensation. While class actions treat all plaintiffs as a single group with uniform compensation, the MDL preserves each plaintiff’s individual claim, allowing for case-specific damages based on injury severity, exposure duration, and personal circumstances that reflect the actual harm suffered. This individualized approach means that someone who developed lung cancer after ten years of CPAP use may receive different compensation than someone with respiratory irritation after two years, ensuring fair outcomes that reflect actual harm rather than averaged settlements that may undervalue serious injuries. The MDL process has already produced significant progress, including comprehensive discovery revealing internal Philips documents, coordinated scientific testing of foam degradation, and the framework for the settlement program announced in May 2024, though many questions remain about eligibility and compensation levels that require careful legal analysis.
This section explains how the federal litigation works and what it means for your case. You’ll learn about the MDL process, how it differs from a class action, and what progress has been made toward resolving claims.
This section breaks down the settlement program and what compensation may be available. You’ll understand how the points system works, what deadlines matter, and whether settling or continuing litigation makes sense for your situation.
The $1.1 billion settlement fund announced in May 2024 represents a significant step toward compensating CPAP victims, though understanding its structure and limitations remains crucial for making informed decisions about your legal options and whether participation serves your best interests. According to MDL court documents (MDL Court, 2024), the settlement employs a points-based distribution system that considers multiple factors including injury type, severity, duration of device use, and age at diagnosis to calculate individual compensation amounts that reflect the varying degrees of harm suffered by different victims. This structured approach aims to provide faster resolution than traditional litigation while ensuring that those with the most serious injuries may receive proportionally higher compensation, though some victims may find that pursuing individual lawsuits outside the settlement yields better results depending on their specific circumstances and the strength of their causation evidence.
Registration requirements and deadlines create urgency for anyone considering participation in the settlement program, as missing these deadlines could forfeit your right to compensation through this streamlined process and limit your options for recovery. The settlement distinguishes between represented and unrepresented claimants, with different registration windows and documentation requirements for each category, making legal representation valuable for navigating these complex procedures and ensuring you meet all necessary deadlines. Importantly, the settlement includes both opt-in provisions for those who wish to participate and opt-out rights for those who prefer to pursue individual litigation, though the decision between these paths requires careful evaluation of your specific circumstances, injury severity, and long-term medical prognosis in consultation with experienced counsel.
Within the broader settlement structure, the Extraordinary Injury Fund provides additional compensation for victims whose injuries exceed standard settlement parameters, recognizing that some cases involve exceptional harm requiring enhanced recovery beyond base compensation tiers. This fund, allocated between $75 million and $150 million according to settlement documents, serves claimants with particularly severe injuries, multiple cancer diagnoses, or cases involving wrongful death where standard settlement tiers may not adequately address the full scope of damages including lost future earnings and lifelong medical needs. Qualification for EIF compensation requires meeting specific medical criteria and providing comprehensive documentation that demonstrates why your case warrants extraordinary consideration beyond base settlement amounts, which typically involves detailed medical record review and expert physician assessments. The application process for extraordinary injury designation involves detailed medical record review, expert physician assessments, and potentially additional discovery to establish the exceptional nature of your injuries and their connection to CPAP use in ways that distinguish your case from typical claims. Claimants who initially receive standard settlement offers retain reconsideration rights if their conditions worsen or if new medical evidence emerges supporting extraordinary injury classification, providing important flexibility for those whose health continues to deteriorate after initial evaluation. Understanding these enhanced compensation opportunities becomes particularly important for younger victims facing decades of future medical costs, those who’ve undergone extensive cancer treatment with lasting complications, or families who’ve lost loved ones to CPAP-related diseases and face both economic and emotional losses that standard compensation may not fully address.
This section breaks down the settlement program and what compensation may be available. You’ll understand how the points system works, what deadlines matter, and whether settling or continuing litigation makes sense for your situation.
Identifying whether your specific device falls within the recall requires checking model numbers and serial numbers against Philips’ comprehensive recall list, as not every CPAP or BiPAP machine is affected despite the widespread nature of this crisis that has touched millions of sleep apnea patients. The recall encompasses numerous DreamStation models including the original DreamStation, DreamStation Go, and DreamStation 2, along with various BiPAP devices such as the BiPAP A30, A40, and S/T models, plus hospital-grade ventilators like the Trilogy series that serve critically ill patients who depend on these devices for survival. Each device category presents unique exposure risks based on usage patterns, with home CPAP users typically experiencing eight hours of nightly exposure while ventilator-dependent patients may face continuous 24-hour exposure to degraded foam particles, creating different injury profiles and potentially different compensation considerations.
Preserving your device as evidence becomes crucial for supporting your legal claim, even if Philips has requested its return through the recall process that aims to remove defective units from circulation. Before returning any device, photograph all labels showing model and serial numbers, document any visible foam degradation or black particles that may indicate advanced breakdown, and consult with an attorney about evidence preservation requirements that could strengthen your case by providing physical proof of the defect. Many St. Louis-area durable medical equipment suppliers who distributed these devices have recall information and can help verify whether your specific machine is affected, though legal representation ensures proper documentation and evidence handling throughout the claims process in ways that protect your interests. The widespread distribution of these devices through major medical suppliers, sleep clinics, and hospitals across Missouri means that thousands of local residents may have valid claims without realizing their device is part of the recall, which is why we encourage anyone who used a Philips CPAP or BiPAP machine to contact our team for a free case evaluation.
This section explains Missouri law and how it affects your case timeline and options. You’ll understand the statute of limitations, how Missouri law differs from neighboring states, and what evidence you need to preserve.
Missouri law provides specific protections and deadlines that shape your ability to pursue compensation for CPAP-related injuries, making it essential to understand how state statutes apply to your individual situation and what steps you must take to preserve your rights. Under Missouri’s five-year statute of limitations for personal injury claims (RSMo §516.120, current), most CPAP lawsuits must be filed within five years of when the injury was discovered or reasonably should have been discovered, though this timeline can vary based on when you learned about the recall, when symptoms appeared, or when you received a diagnosis linking your condition to CPAP use through medical evaluation. The approaching June 2026 deadline—marking five years since the initial recall announcement—creates particular urgency for those who’ve delayed seeking legal counsel, though the discovery rule may extend this deadline for victims whose injuries manifested later or who couldn’t reasonably connect their health problems to their CPAP device without medical investigation.
The differences between Missouri and Illinois law can significantly impact your case strategy and potential recovery, particularly if you live near the state border or received medical treatment in both states where different legal standards may apply. While Missouri follows pure comparative fault rules that allow recovery even if you bear some responsibility for your injuries, Illinois applies modified comparative fault that bars recovery if you’re more than 50% at fault, potentially affecting cases where defendants argue that ozone cleaner use or failure to register for recall replacement contributed to your injuries through product misuse. Additionally, Missouri’s approach to punitive damages, with caps set at five times compensatory damages or $500,000, whichever is greater, differs from Illinois law and may influence venue decisions for cases with strong evidence of corporate misconduct that could support enhanced damages.
Evidence preservation requirements under Missouri law mandate maintaining not just the device itself but also purchase receipts, medical records showing CPAP prescription and usage, and documentation of any symptoms or diagnoses potentially related to foam exposure, all of which strengthen your claim by establishing the connection between device use and injury.
This section explains Missouri law and how it affects your case timeline and options. You’ll understand the statute of limitations, how Missouri law differs from neighboring states, and what evidence you need to preserve.
This section explains our approach and what you can expect when working with our team. You’ll learn about our experience, resources, and commitment to pursuing fair compensation without upfront costs.
Our approach to CPAP litigation combines deep knowledge of product liability law with specific expertise in medical device failures and the unique scientific challenges these cases present, drawing on decades of experience representing injured victims against major corporations. We’ve assembled a network of medical experts specializing in pulmonology, oncology, and toxicology who can establish the causal connection between foam exposure and your injuries, providing the scientific foundation necessary to overcome defense challenges and pursue maximum recovery through settlement negotiations or trial if necessary. Our investigative team has extensively reviewed internal Philips documents, FDA enforcement records, and independent testing data to build compelling narratives that demonstrate not just product defect but corporate knowledge and delayed action that may prove persuasive to settlement administrators or juries evaluating your claim.
The complexity of CPAP cases requires resources that many law firms simply cannot provide, which is why we handle these cases on a contingency fee basis with no upfront costs to our clients, ensuring that financial concerns don’t prevent you from pursuing justice. This means we advance all litigation expenses—including expert witness fees that can exceed $50,000 in complex medical device cases, discovery costs, and trial preparation—and only collect fees if we successfully recover compensation for you through settlement or verdict. Our settlement negotiation approach balances the desire for quick resolution with the need for fair compensation, carefully evaluating settlement offers against the potential value of continued litigation while keeping you informed and empowered to make decisions about your case that align with your priorities and circumstances. We understand that behind every CPAP case is a person whose life has been disrupted by corporate negligence, and we’re committed to pursuing the justice and compensation you may be entitled to while treating you with the respect and compassion you deserve during this difficult time.
The CPAP recall stands apart from typical medical device failures due to its massive scope, affecting over 15 million devices globally, and the unique exposure mechanism that delivered toxins directly into users’ airways for hours each night over years or decades of use. Unlike hip implants or hernia mesh that affect specific surgical patients, CPAP devices were prescribed to millions of sleep apnea sufferers who used them religiously, trusting that these FDA-regulated devices were safe for long-term respiratory therapy without knowing about the foam degradation risks. The settlement structure also differs significantly from other device recalls, employing a points-based system that accounts for various injury types and exposure durations rather than uniform payments, while the sheer volume of affected users has created one of the largest MDL consolidations in federal court history with implications for how future mass tort cases may be handled.
Determining whether your injury may qualify for compensation requires evaluating both your medical diagnosis and your history of CPAP use, with stronger claims generally involving documented respiratory or cancer diagnoses that developed after sustained device use over months or years. Qualifying conditions typically include various cancers (particularly lung, throat, and sinus), respiratory diseases like COPD or pulmonary fibrosis, and other systemic conditions potentially linked to chemical exposure, though even less severe injuries may warrant compensation depending on their impact on your life and required medical treatment that creates economic losses. The duration of your CPAP use plays a crucial role, as longer exposure periods strengthen the causal connection, while factors like your age, overall health, and absence of other risk factors can enhance your claim’s value within settlement frameworks or at trial, though every case requires individual evaluation by experienced counsel who can assess your specific circumstances.
Settlement registration deadlines vary depending on whether you have legal representation and when you first learned about your potential claim, making immediate consultation with an attorney crucial to preserve your rights and ensure you don’t miss critical filing windows. The MDL settlement includes specific windows for represented and unrepresented claimants, with different requirements for documentation and claim submission that can affect both your eligibility and potential recovery amount in ways that may not be immediately apparent without legal guidance. Missing these deadlines could forfeit your right to participate in the streamlined settlement process, though individual lawsuits may remain viable depending on Missouri’s statute of limitations and when your injury became apparent through medical diagnosis, highlighting why prompt legal action protects all available options and maximizes your potential recovery.
Returning your CPAP device to Philips doesn’t prevent you from filing a lawsuit, though preserving evidence through photographs, serial number documentation, and medical records becomes even more critical for proving your case without the physical device available for inspection. Many successful claims proceed without the physical device by relying on purchase records, prescription documentation, insurance claims showing CPAP supply orders, and medical records confirming device use during the relevant period, all of which can establish the necessary connection between your exposure and injury. If you haven’t yet returned your device, consulting with an attorney before doing so ensures proper evidence preservation, including professional photography of any visible degradation and chain-of-custody documentation that maintains the evidence’s legal validity and strengthens your claim by providing physical proof of the defect.
The settlement employs a sophisticated points-based matrix that assigns values to different factors including injury severity, type of cancer or disease, duration of device use, age at diagnosis, and other case-specific variables that affect overall compensation in ways designed to reflect individual harm. Higher point values typically accompany more severe injuries like lung cancer in non-smokers, younger victims facing longer-term impacts, and cases with extensive medical documentation showing clear causation between CPAP use and diagnosed conditions through expert medical testimony. This calculation system aims to provide proportional compensation that reflects individual harm while maintaining consistency across similar cases, though victims retain the right to opt out and pursue individual litigation if they believe the settlement undervalues their specific injuries or doesn’t adequately address their long-term medical needs and economic losses.
The CPAP litigation involves two distinct settlement funds addressing different types of harm: the economic loss settlement compensates for device purchase costs and related economic damages, while the personal injury settlement addresses medical expenses, pain and suffering, and other damages from physical injuries that require medical treatment. Economic loss claims typically involve smaller amounts and cover those who used recalled devices but haven’t developed physical injuries, providing refunds or replacement device costs without requiring proof of medical harm beyond the inconvenience and expense of device replacement. Personal injury settlements offer substantially higher compensation but require medical documentation of qualifying conditions, with the $1.1 billion fund specifically allocated for those who’ve suffered documented health consequences from foam exposure rather than mere economic losses from purchasing a defective product, though both types of claims may be available depending on your circumstances.
With over $5 billion recovered in negotiated settlements for clients across all practice areas and a dedicated team that combines extensive legal experience with trauma-informed representation, OnderLaw brings both the resources and compassion necessary to handle these deeply personal cases effectively while prioritizing your healing and privacy throughout the process. Our approach goes beyond traditional legal representation to include connecting you with networks of expert witnesses, therapists, and support resources while maintaining the strictest confidentiality, because we understand that healing from sexual abuse requires comprehensive support that addresses both legal and personal needs. The trauma-informed approach we take recognizes that every survivor’s journey is different, which is why we tailor our representation to your specific needs, whether that means minimizing the number of times you need to tell your story, coordinating with your therapeutic team, or pursuing strategies that prioritize privacy over maximum publicity.
Time is running out to pursue compensation for injuries caused by recalled Philips CPAP devices, with critical deadlines approaching that could forever bar your right to recovery if missed due to statute of limitations expiration. The five-year statute of limitations under Missouri law means that many claims must be filed before June 2026, while settlement registration deadlines may close even sooner, making immediate action essential to preserve all available legal options and maximize your potential recovery. Whether you’re dealing with a recent cancer diagnosis, struggling with respiratory problems that won’t improve despite treatment, or mourning the loss of a loved one who used these devices, you deserve answers about your legal rights and potential compensation—which is why we offer free consultations to evaluate your case without any obligation or upfront costs that might prevent you from seeking justice.
Call us today at (314) 408-6136 to schedule your free consultation and learn how we may be able to help you pursue the justice and compensation you deserve for the harm caused by these dangerously defective devices that were supposed to help you breathe safely.
Our free consultation helps you understand your rights and options.
